PMC9974160_01
Serum bile acids in response to therapies. The start of Odevixibat therapy (orange arrow) coincides with a considerable reduction in serum bile acids compared to when the patient was treated only with UDCA (25 mg/kg/day) and rifampicin (5 mg/kg/day). mo, months; UDCA, ursodeoxycholic acid; Y, years.
fped-11-1061535-g001.jpg
PMC9974160_01_fped-11-1061535-g001.jpg
F1
At three months the absolute change of serum BA from baseline was of less 387 mumol/L (Figure 1).